| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K16147474 |
| PharmacoGx | BRD-K16147474 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MARVELD2 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0007 |
| mRNA | DEFB112 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | MZB1 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0007 |
| mRNA | GALNTL6 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0007 |
| mRNA | CDKN2AIPNL | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0008 |
| mRNA | GATSL2 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0008 |
| mRNA | COLQ | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0008 |
| mRNA | ZNF646 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0008 |
| mRNA | CNTD2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | NHSL2 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0008 |
